Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lipocine Inc.

    NASDAQ: LPCN · Real-Time Price · USD
    3.11
    -0.01 (-0.38%)
    At close: Jun 06, 2025, 3:59 PM
    3.02
    -2.89%
    After-hours: Jun 06, 2025, 04:21 PM EDT

    Lipocine Statistics

    Share Statistics

    Lipocine has 5.35M shares outstanding. The number of shares has increased by 0.05% in one year.

    Shares Outstanding

    n/a
    		 5.35M

    Shares Change (YoY)

    n/a
    		 0.05%

    Shares Change (QoQ)

    n/a
    		 0.05%

    Owned by Institutions (%)

    n/a
    		 11.32%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 6

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 84.97K, so 1.59% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 84.97K

    Short % of Shares Out

    n/a
    		 1.59%

    Short % of Float

    n/a
    		 1.64%

    Short Ratio (days to cover)

    n/a
    		 2.04

    Valuation Ratios

    The PE ratio is 3119.51 and the forward PE ratio is -2.05. Lipocine's PEG ratio is -31.18.

    PE Ratio

    n/a
    		 3119.51

    Forward PE

    n/a
    		 -2.05

    PS Ratio

    n/a
    		 2.33

    Forward PS

    n/a
    		 1.9

    PB Ratio

    n/a
    		 1.24

    P/FCF Ratio

    n/a
    		 -19.87

    PEG Ratio

    n/a
    		 -31.18
    Financial Ratio History

    Enterprise Valuation

    Lipocine has an Enterprise Value (EV) of 19.85M.

    EV / Sales

    n/a
    		 1.77

    EV / EBITDA

    n/a
    		 -17.82

    EV / EBIT

    n/a
    		 -16.25

    EV / FCF

    n/a
    		 -15.14

    Financial Position

    The company has a current ratio of 14.75, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 14.75

    Quick Ratio

    n/a
    		 14.75

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 0.04% and Return on Invested Capital is -5.09%.

    Return on Equity

    n/a
    		 0.04%

    Return on Assets

    n/a
    		 0.04%

    Return on Invested Capital

    n/a
    		 -5.09%

    Revenue Per Employee

    n/a
    		 $699,884

    Profits Per Employee

    n/a
    		 $522

    Employee Count

    n/a
    		 16

    Asset Turnover

    n/a
    		 0.5

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 681

    Effective Tax Rate

    n/a
    		 7.54%

    Stock Price Statistics

    The stock price has increased by -55.23% in the last 52 weeks. The beta is 1.33, so Lipocine's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.33

    52-Week Price Change

    n/a
    		 -55.23%

    50-Day Moving Average

    n/a
    		 3.26

    200-Day Moving Average

    n/a
    		 4.15

    Relative Strength Index (RSI)

    n/a
    		 41.74

    Average Volume (20 Days)

    n/a
    		 30,588

    Income Statement

    In the last 12 months, Lipocine had revenue of 11.2M and earned 8.35K in profits. Earnings per share was 0.

    Revenue

    n/a
    		 11.2M

    Gross Profit

    n/a
    		 3.85M

    Operating Income

    n/a
    		 -1.16M

    Net Income

    n/a
    		 8.35K

    EBITDA

    n/a
    		 -1.11M

    EBIT

    n/a
    		 -1.16M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 6.21M in cash and 0 in debt, giving a net cash position of 6.21M.

    Cash & Cash Equivalents

    n/a
    		 6.21M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -199.77M

    Total Assets

    n/a
    		 20.5M

    Working Capital

    n/a
    		 19.03M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -1.22M and capital expenditures -90.09K, giving a free cash flow of -1.31M.

    Operating Cash Flow

    n/a
    		 -1.22M

    Capital Expenditures

    n/a
    		 -90.09K

    Free Cash Flow

    n/a
    		 -1.31M

    FCF Per Share

    n/a
    		 -0.25
    Full Cash Flow Statement

    Margins

    Gross margin is 34.35%, with operating and profit margins of -10.31% and 0.07%.

    Gross Margin

    n/a
    		 34.35%

    Operating Margin

    n/a
    		 -10.31%

    Pretax Margin

    n/a
    		 0.08%

    Profit Margin

    n/a
    		 0.07%

    EBITDA Margin

    n/a
    		 -9.95%

    EBIT Margin

    n/a
    		 -10.31%

    FCF Margin

    n/a
    		 -11.71%

    Dividends & Yields

    LPCN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0.03%

    FCF Yield

    n/a
    		 -5.03%
    Dividend Details

    Analyst Forecast

    The average price target for LPCN is $9, which is 183.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9

    Price Target Difference

    n/a
    		 183.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 0.37

    Graham Upside

    n/a
    		 -88.33%

    Stock Splits

    The last stock split was on May 12, 2023. It was a backward split with a ratio of 1:17.

    Last Split Date

    n/a
    		 May 12, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:17

    Scores

    Altman Z-Score

    n/a
    		 -5.37

    Piotroski F-Score

    n/a
    		 0

    Add to Watchlist